Contact Information
E-mail: kopnov98@mail.ru
Brief Biography
Ivan Sergeyevich Kopnov graduated with honors from the Faculty of Biomedical Sciences at the Siberian State Medical University in 2026, specializing in Medical Biochemistry. That same year, he began his postgraduate studies at the Tomsk National Research Medical Center (Tomsk NRMC) in the field of Psychiatry and Narcology (specialty code 3.1.17).
In 2026, he was appointed as a junior researcher in the Laboratory of Molecular Psychiatry at the Mental Health Research Institute.
Research Interests
Molecular biology, genetics, schizophrenia, and molecular markers of mental disorders.
Achievements, awards, and grants:
I. S. Kopnov has participated in over 8 scientific conferences at various levels, delivering both oral and poster presentations. He has repeatedly received awards and certificates of merit for his outstanding presentations.
Ivan Kopnov has served as a researcher/contributor on the following projects:
1. RSF Grant No. 23-75-10072: "BDNF-mediated intracellular signaling cascades in the clinical polymorphism and cognitive deficit associated with schizophrenia," 2023–2026.
2. RSF Grant No. 25-15-00344: "Constitutional-biological predictors of the risk of suicidal behavior in patients with schizophrenia," 2025–2027.
3. RSF Grant No. 26-25-00301: "The role of non-enzymatic protein glycosylation in the pathogenesis of schizophrenia and antipsychotic-induced metabolic syndrome," 2027–2028.
Publication activity:
1. Boiko AS, Kopnov IS, Epimakhova EV, Kornetova EG, Ivanova SA. MAPK/ERK Signaling Pathway in Schizophrenia: Expression Levels of Regulatory Proteins in Peripheral Blood Mononuclear Cells. Biochemistry (Mosc). 2026 Feb;91(2):299-308. doi: 10.1134/S0006297925603466. (Scopus Q2, Web of Science)
2. Boiko A.S., Paderina D.Z., Mikhalitskaya E.V., Kopnov I.S., Kornetova E.G., Ivanova S.A. Polymorphic variants of genes involved in BDNF-mediated protein kinase signaling pathways in patients with schizophrenia: association analysis and functional gene annotation. Siberian Bulletin of Psychiatry and Addiction. 2026. No. 1 (130). pp. 5–17. https://doi.org/10.26617/1810-3111-2026-1(130)-5-17. (Scopus Q4)
3. Boiko A.S., Kopnov I.S., Mikhalitskaya E.V., Paderina D.Z., Kornetova E.G., Ivanova S.A., Kornetov A.N. The JNK/p38 signaling pathway in schizophrenia: a pilot study of protein expression levels in blood mononuclear cells of patients in relation to clinical features of the disease. Bulletin of Siberian Medicine. 2026;26(4). (Scopus Q4, Web of Science Q4,)
4. Zykova M.V., Ivanov V.V., Larionov K.S., Azarkina L.A., Buyko E.E., Bratishko K.A., Ufandeev A.A., Rabtsevich E.S., Mikhalev D.A., Kopnov I.S., Perminova I.V., Belousov M.V. Investigation of the wound-healing properties of zinc complexes with humic substances: an in vivo experiment using an aseptic wound model // Bulletin of Siberian Medicine. – 2023. – Vol. 22, No. 4. – pp. 39-47. – DOI 10.20538/1682-0363-2023-4-39-47. (Scopus Q4, Web of Science Q4,).
5. Bratishko K.A., Kuznetsova M.V., Zhirkova A.M., Ivanov V.V., Buyko E.E., Ufandeev A.A., Azarkina L.A., Mikhalev D.A., Kopnov I.S., Perminova I.V., Zykova M.V. Correction of acute posthemorrhagic anemia in rats using iron(III) hydroxocomplexes stabilized by humic macroligands // Cardiovascular Therapy and Prevention. – 2024. – Vol. 23, No. S6. – pp. 131-132. (Scopus Q4).
Intellectual Property Assets (IPAs):
1. Database Registration Certificate No. 2026622245, Russian Federation. Clinical characteristics and polymorphisms of genes involved in BDNF-mediated intracellular signaling cascades in patients with schizophrenia / Kopnov I.S., Boiko A.S., Paderina D.Z., Mikhalitskaya E.V., Petkun D.A., Vyalova N.M., Kornetov A.N., Kornetova E.G., Ivanova S.A.; applicant and rights holder: Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences" (RU); Application No. 2026622028/69; filed May 3, 2026; published May 19, 2026.
2. Database Registration Certificate No. 2026624643, Russian Federation. Sociodemographic parameters, clinical factors, and indicators of neurodestruction and neuroplasticity in patients with schizophrenia and metabolic syndrome / Ivanova S.A., Mednova I.A., Boiko A.S., Shternis Yu.V., Kopnov I.S., Matveychuk D.E., Kornetov A.N., Kornetova E.G., Bokhan N.A.; applicant and rights holder: Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences" (RU); Application No. 2026624489; filed September 22, 2026; published September 29, 2026.